My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Legend Biotech Corporation - American Depositary Shares (NQ:LEGN)

31.71 -0.35 (-1.09%)
Streaming Delayed Price Updated: 1:43 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 702,906
Open 32.10
Bid (Size) 31.68 (1)
Ask (Size) 31.73 (1)
Prev. Close 32.06
Today's Range 31.39 - 32.62
52wk Range 27.34 - 51.77
Shares Outstanding 308,456,852
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Amgen Surges on Repatha Expansion, Manufacturing Boost, and Strong Earnings
Thousand Oaks, CA – October 2, 2025 – Amgen (NASDAQ: AMGN) has witnessed a robust surge in its share price, climbing approximately 6% in recent trading sessions, culminating on October 2, 2025, to... 
Via MarketMinute
Topics Economy Intellectual Property Stocks
How Do Investors Really Feel About Legend Biotech?
 
Via Benzinga

Performance

YTD
-8.7%
-8.7%
1 Month
-12.1%
-12.1%
3 Month
-11.6%
-11.6%
6 Month
+4.8%
+4.8%
1 Year
-36.0%
-36.0%

More News

Read More
Legend Biotech Considering Second Listing Outside US: Report
Via Stocktwits
How Do Investors Really Feel About Legend Biotech?
Via Benzinga
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
From Legend Biotech USA Inc.
Via GlobeNewswire
Earnings Outlook For Legend Biotech
Via Benzinga
Looking Into Legend Biotech's Recent Short Interest
Via Benzinga
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
From Legend Biotech USA Inc.
Via GlobeNewswire
The Analyst Verdict: Legend Biotech In The Eyes Of 5 Experts
Via Benzinga
Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports
Via MarketMinute
Topics Economy Stocks
Is Legend Biotech Gaining or Losing Market Support?
Via Benzinga
What Does the Market Think About Legend Biotech?
Via Benzinga
Legend Biotech Corp. (NASDAQ:LEGN) Reports Mixed Q2 2025 Earnings with Revenue Beat and EPS Miss Amid Strong CARVYKTI Sales
Via Chartmill
Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights
From Legend Biotech USA Inc.
Via GlobeNewswire
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results
From Legend Biotech USA Inc.
Via GlobeNewswire
A Glimpse Into The Expert Outlook On Legend Biotech Through 6 Analysts
Via Benzinga
Earnings Scheduled For August 11, 2025
Via Benzinga
The FDA Shake-Up Continues, And Could Impact Genetic Medicines
Via Investor's Business Daily
Topics Government
Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday
Via Benzinga
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
From Legend Biotech USA Inc.
Via GlobeNewswire
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
From Legend Biotech USA Inc.
Via GlobeNewswire
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
From Legend Biotech USA Inc.
Via GlobeNewswire
Legend Biotech Reports First Quarter 2025 Results and Recent Highlights
From Legend Biotech USA Inc.
Via GlobeNewswire
Earnings Scheduled For May 13, 2025
Via Benzinga

Frequently Asked Questions

Is Legend Biotech Corporation - American Depositary Shares publicly traded?
Yes, Legend Biotech Corporation - American Depositary Shares is publicly traded.
What exchange does Legend Biotech Corporation - American Depositary Shares trade on?
Legend Biotech Corporation - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Legend Biotech Corporation - American Depositary Shares?
The ticker symbol for Legend Biotech Corporation - American Depositary Shares is LEGN on the Nasdaq Stock Market
What is the current price of Legend Biotech Corporation - American Depositary Shares?
The current price of Legend Biotech Corporation - American Depositary Shares is 31.71
When was Legend Biotech Corporation - American Depositary Shares last traded?
The last trade of Legend Biotech Corporation - American Depositary Shares was at 10/06/25 01:43 PM ET
What is the market capitalization of Legend Biotech Corporation - American Depositary Shares?
The market capitalization of Legend Biotech Corporation - American Depositary Shares is 9.78B
How many shares of Legend Biotech Corporation - American Depositary Shares are outstanding?
Legend Biotech Corporation - American Depositary Shares has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.